^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GSK5764227

    i
    Other names: GSK5764227, HS-20093, HS20093, HS 20093, GSK 5764227, GSK-5764227, GSK’227
    Associations
    News

    Trials

    Company:
    GSK, Jiangsu Hansoh Pharma
    Drug class:
    Topoisomerase I inhibitor, B7-H3-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News

    Trials

    Apply
    Phase Ib Trial of HS-20117 in Combination with Other Drugs in Advanced Solid Tumors (NCT06621563)
    Phase 1
    Hansoh BioMedical R&D Company
    Not yet recruiting
    Last update posted :
    10/01/2024
    Initiation :
    12/01/2024
    Primary completion :
    03/30/2026
    Completion :
    12/01/2026
    BRAF
    |
    cisplatin • carboplatin • 5-fluorouracil • GSK5764227 • PM1080